From: Covid-19 associated ARDS in pregnant women and timing of delivery: a single center experience
 | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | Patient 8 | Patient 9 | Patient 10 | Patient 11 | Patient 12 | Patient 13 | Patient 14 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Maternal factors | ||||||||||||||
Age (years) | 37 | 34 | 38 | 27 | 29 | 30 | 39 | 28 | 32 | 26 | 38 | 28 | 34 | 21 |
Weight (kg) | 90 | 97 | 70 | 124 | 85 | 87 | 103 | 60 | 90 | 130 | 75 | 72 | 70 | 60 |
BMI | 29 | 34 | 27 | 44 | 32 | 33 | 39 | 23 | 35 | 42 | 27 | 29 | 26 | 22 |
Gravida/Para | G6/P5 | G4/P3 | G4/P3 | G1/P0 | G2/P1 | G1/P0 | G2/P1 | G1/P0 | G5/P4 | G4/P1 | G8/P3 | G1/P0 | G3/P2 | G2/P1 |
Gestational age (admission ICU) | 26 | 34 | 22 | 28 | 38 | 33 | 22 | 28 | 24 | 19 | 21 | 31 | 17 | 26 |
Comorbidities | Eclampsia | HIV, hepatitis B |  | Obesitas | Asthma | Thalassemia | Obesitas |  |  | Arterial hypertension | Diabetes, arterial hypertension |  | Pyelonephritis |  |
Days on ICU | 16 | 64 | 52 | 9 | 33 | 38 | 2 | 5 | 10 | 2 | 11 | 6 | 23 | 21 |
Maternal Covid-19 | ||||||||||||||
Symptom onset (days) | 8 | 6 | 4 | 8 | 9 | 7 | 5 | 10 | 9 | n.a | 8 | 10 | 7 | n.a |
Covid-19 diagNosis | PCR | PCR | PCR | PCR | PCR | PCR | PCR | PCR | PCR | PCR | PCR | PCR | PCR | PCR |
CRP (mg/l) | 172 | 115 | 135 | 88 | 119 | 60 | 31 | 138 | 109 | 75 | 174 | 60 | 65 | 184 |
PCT (mcg/l) | 0.2 | 0.2 | 0.2 | 0.2 | 0.6 | 0.7 | 0.2 | 0.3 | 0.1 | 0.1 | 0.5 | 0.8 | 0.8 | 0.6 |
White-cell count (× 10−3/mm3) | 21.7 | 9.2 | 7.8 | 7.2 | 10.7 | 13.1 | 7.2 | 11.8 | 7.2 | 7.5 | 11.8 | 9.8 | 7.3 | 14.2 |
LDH (U/l) | 435 | 299 | 379 | 569 | 425 | 464 | 195 | 408 | 393 | 364 | 351 | 310 | 462 | 432 |
Troponin (ng/l) | 29 | 6 |  < 3.3 | n.a | 4 | 5 | 4 | 4 | 9 | n.a | 10 | 4 |  < 3.3 | 5 |
Ferritin (mcg/l) | 193 | 76 | 94 | 337 | 179 | 201 | 43 | 99 | 151 | 221 | 171 | 105 | 749 | 290 |
D-Dimer (mg/l) | 3.33 | 2.01 | 1.23 | 2.26 | 1.69 | 2.63 | 1.58 | 2.5 | 0.59 | 0.69 | 1.81 | 6.39 | 0.82 | 1.02 |
Fibrinogen (g/l) | 6.98 | 5.82 | 6.5 | 6.1 | n.a | 3.9 | n.a | n.a | 5.79 | 6.13 | n.a | 3.73 | n.a | n.a |
Invasive ventilation | Yes | Yes | Yes | Yes | Yes | Yes | No | No | Yes | No | Yes | No | Yes | Yes |
PEEP/plateau (cm/H2O) | 16/32 | 10/26 | 12/27 | 15/13 | 15/16 | 15/15 | n.a | n.a | 16/18 | n.a | 16/15 | n.a | 12/16 | 14/16 |
Horowitz/PF ratio | 78 | 61 | 62 | 48 | 56 | 70 | 96 | 95 | 112 | 78 | 31 | 67 | 84 | 92 |
Prone positioning during pregnancy | No | No | Yes | Yes | No | No | No | No | Yes | No | Yes | No | Yes | No |
ECMO | Yes | Yes | Yes | Yes | Yes | Yes | No | No | No | No | No | No | No | No |
Covid-19 targeted therapy | Remdesivir | No | Tocilizumab | No | Tocilizumab | Tocilizumab | No | No | No | Tocilizumab | No | Remdesivir | Remdesivir | Tocilizumab |
Systemic steroids | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes |
Vasoactives | Yes | Yes | Yes | Yes | Yes | Yes | No | No | Yes | No | Yes | No | Yes | Yes |
AKI | Yes | Yes | No | Yes | Yes | No | No | No | No | No | Yes | No | No | No |
Dialysis | Yes | No | No | Yes | Yes | No | No | No | No | No | Yes | No | No | No |
Heart failure | No | Yes | No | Yes | Yes | No | No | No | No | No | Yes | No | No | No |
SOFA score ad admission | 9 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 7 | 5 | 8 | 2 | 3 | 3 |
Maternal survival to hospital discharge | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes |
Unborn/newborn survival to hospital discharge | No | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | No | Yes |
Abortion/stillborn | Yes | No | No | Yes | No | No | No | No | No | No | Yes | No | Yes | No |
Delivery during ICU | No | C-section | C-section | C-section | C-section | C-section | No | No | No | No | Transvaginal | No | Transvaginal | No |